Skip to main content

Advertisement

SpringerLink
Log in

The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the expression patterns of IGF2 and IMP3 in osteosarcoma as well as its relationship with angiogenesis in the tumor. IGF2 and IMP3 expression was detected by immunohistochemical staining in the serial sections of the osteosarcoma. The impacts of IGF2 and IMP3 expression patterns on tumor angiogenesis were evaluated by statistics. The IGF2 and IMP3 staining had different expression patterns in different osteosarcoma. Twelve out of the sixty-four cases of conventional osteosarcoma showed nuclear staining patterns, and twenty-nine showed cytoplasmic staining of IGF2 and IMP3 simultaneously. On the other hand, fourteen cases showed nuclear IGF2 staining but cytoplasmic IMP3 expression, and nine cases showed nuclear IMP3 staining and cytoplasmic IGF2 expression. Twenty-eight out of forty-seven cases of parosteal osteosarcoma showed nuclear IGF2 and IMP3 expression, nine showed cytoplasmic IGF2 and IMP3 expression simultaneously. Seven out of forty-seven cases of parosteal osteosarcoma expressed IGF2 with nuclear staining but expressed IMP3 with cytoplasmic staining. Meanwhile, three cases expressed IGF2 with cytoplasmic staining but expressed IMP3 with nuclear staining. Similar to the parosteal osteosarcoma, the periosteal osteosarcoma expressed IGF2 and IMP3 mainly with nuclear staining simultaneously, forty out of fifty-five cases of periosteal osteosarcoma did that. Five out of fifty-five cases expressed IGF2 and IMP3 with cytoplasmic staining at the same time. Four cases showed nuclear IGF2 staining and cytoplasmic IMP3 staining. In the parosteal and periosteal osteosarcoma, there was no significant difference in IGF and IMP3 expression patterns (P = 0.216). However, compared with conventional osteosarcoma, the parosteal and periosteal osteosarcoma showed significant difference in IMP3 and IGF2 expression (P = 0.016, P = 0.023). IGF2 and IMP3 expression patterns were positive correlation in the different osteosarcoma (r = 0.1021, P = 0.032). The Microvessel density (MVD) in osteosarcoma with IGF2 and IMP3 cytoplasmic staining was more than that with nuclear expression of IGF2 and IMP3, and the difference was significant (P = 0.024). Moreover, the conventional osteosarcoma with cytoplasmic IGF and IMP3 showed more MVD than parosteal and periosteal osteosarcoma with cytoplasmic IGF and IMP3, and the difference was significant (P = 0.035). IGF2 and IMP3 had different expression patterns, which might be associated with angiogenesis. However, cytoplasmic and nuclear expression of IGF2 and IMP3 might play different roles in the angiogenesis of osteosarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1(3):219–227

    Article  PubMed  CAS  Google Scholar 

  • Al-Romaih K, Somers GR, Bayani J (2007) Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation. Cancer Cell Int 7:14

    Article  PubMed  Google Scholar 

  • Amit D, Tamir S, Birman T, Gofrit ON, Hochberg A (2011) Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2–P3 and IGF2–P4 regulatory sequences. Int J Clin Exp Med 4(2):91–102

    PubMed  Google Scholar 

  • Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Nicola B (2009) Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res 69(6):2443–2452

    Article  PubMed  CAS  Google Scholar 

  • Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82

    PubMed  CAS  Google Scholar 

  • Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332(3):F105–F126

    PubMed  CAS  Google Scholar 

  • Bautista CM, Baylink DJ, Mohan S (1991) Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGFII in human bone. Biochem Biophys Res Commun 176:756–763

    Article  PubMed  CAS  Google Scholar 

  • Beasley NJ, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62(5):1315–1320

    PubMed  CAS  Google Scholar 

  • Bjorndahl M, Renhai Cao L, Nissen J, Clasper S, Johnson LA, Xue Y, Zhou Z, Jackson D, Hansen AJ, Cao Y (2005) Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. PNAS 102(43):15593–15598

    Article  PubMed  Google Scholar 

  • Cao Y (2005) Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5(9):735–743

    Article  PubMed  CAS  Google Scholar 

  • Chava S, Mohan V, Shetty PJ, et al. (2011) Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer. Dis Esophagus. 10 June 2011. doi:10.1111/j.1442-2050.2011.01213.x. [Epub ahead of print]

  • Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90(11):1222–1230

    Article  PubMed  CAS  Google Scholar 

  • Chen ST, Jeng YM, Chang CC, Chang HH, Huang MC, Juan HF, Hsu CH, Lee H, Liao YF, Lee YL, Hsu WM, Lai HS (2011) Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma. Cancer Sci. 14 September 2011. doi:10.1111/j.1349-7006.2011.02100.x. [Epub ahead of print]

  • Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8(1):45–62

    Article  PubMed  CAS  Google Scholar 

  • Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50(1):48–53

    PubMed  CAS  Google Scholar 

  • Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, Jahnke K, Hauschild A, Hirakawa S, Mihm MC, Detmar M (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18(9):1232–1242

    Article  PubMed  Google Scholar 

  • Do SI, Kim YW, Park HR, Park YK (2008) Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma. Oncol Res 17(6):269–272

    Article  PubMed  Google Scholar 

  • Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3(6):453–458

    Article  PubMed  CAS  Google Scholar 

  • Fletcher CDM, Unni KK, Mertens F (eds) (2002) World health organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon

  • Flossmann-Kast BB, Jehle PM, Hoeflich A, Adler G, Lutz MP (1998) Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res 58(16):3551–3554

    PubMed  CAS  Google Scholar 

  • Fokas E, Kamlah F, Hänze J, Engenhart-Cabillic R, Rose F, An HX (2010) EphA2 blockade enhances the anti-endothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cells. Thorac Cancer 1:153–162

    Google Scholar 

  • Guerra FK, Eijan AM, Puricelli L, Alonso DF, de Kier Joffe EB, Kornblihgtt AR, Charreau EH, Elizalde PV (1996) Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Int J Cancer 65:812–820

    Article  PubMed  CAS  Google Scholar 

  • Guo YS, Jin GF Jr, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC (1995) Insulin-like growth factor II expression in carcinoma in colon cell lines: implications for autocrine actions. J Am Coll Surg 181:145–154

    PubMed  CAS  Google Scholar 

  • Hermanto U, Zong CS, Wang LH (2000) Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation. Cell Growth Differ 11:655–664

    PubMed  CAS  Google Scholar 

  • Jenkins PJ, Bustin SA (2004) Evidence for a link between IGF-I and cancer. Eur J Endocrinol 151(Suppl 1):S17–S22

    Article  PubMed  CAS  Google Scholar 

  • Kappel CC, Velez-Yanguas MC, Hirschfeld S, Helman LJ (1994) Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54:2803–2807

    PubMed  CAS  Google Scholar 

  • Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J, Baylink D (1990) Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71(5):1322–1329

    Article  PubMed  CAS  Google Scholar 

  • Kasperk CH, Faehling K, Bo¨rcso¨k I, Ziegler R (1996) Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2. Calcif Tissue Int 58:376–382

    PubMed  CAS  Google Scholar 

  • Kern PA, Svoboda ME, Eckel RH, Van Wyk JJ (1989) Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue. Diabetes 38(6):710–717

    Article  PubMed  CAS  Google Scholar 

  • Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244

    Article  PubMed  CAS  Google Scholar 

  • Lee OH, Bae SK, Bae MH, Lee YM, Moon EJ, Cha HJ, Kwon YG, Kim KW (2000) Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 82(2):385–391

    Article  PubMed  CAS  Google Scholar 

  • Li Y, Meng G, Huang L, Guo QN (2009) Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma. Hum Pathol 40(10):1441–1447

    Article  PubMed  CAS  Google Scholar 

  • Long L, Rubin R, Brodt P (1998) Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res 238(1):116–121

    Article  PubMed  CAS  Google Scholar 

  • Neuhausen SL, Brummel S, Ding YC, et al. (2011) Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiol Biomarkers Prev. 26 July 2011. [Epub ahead of print]

  • Ogawa O, Eccles MR, Szeto J et al (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms’ tumour. Nature 362:749–751

    Article  PubMed  CAS  Google Scholar 

  • Ohlaaon R, Nystrom A, Pfeifer-Ohlsson S et al (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann sindrome. Nat Genet 4:94–97

    Article  Google Scholar 

  • Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F (1996) Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271:11477–11483

    Article  PubMed  CAS  Google Scholar 

  • Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747–749

    Article  PubMed  CAS  Google Scholar 

  • Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM (2002) Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82(10):1377–1389

    PubMed  CAS  Google Scholar 

  • Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M (2002) Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 99(11):7455–7460

    Article  PubMed  CAS  Google Scholar 

  • Rosato R, Gerland K, Jammes H, Bataille-Simoneau N, Segovia B, Mercier L, Groyer A (2001) The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells. Mol Cell Endocrinol 175(1–2):15–27

    Article  PubMed  CAS  Google Scholar 

  • Shigematsu S, Yamauchi K, Nakajima K, Iijima S, Aizawa T, Hashizume K (1999) IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr J 46(Suppl):S59–S62

    Article  PubMed  CAS  Google Scholar 

  • Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z (1996) Overexpression of the insulin-like growth factor I receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 56:1761–1765

    PubMed  CAS  Google Scholar 

  • Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR (2001) AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 61(2):589–593

    PubMed  CAS  Google Scholar 

  • Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B (2007) Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58. J Cell Biochem 102(1):28–40

    Article  PubMed  CAS  Google Scholar 

  • Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O (1999) Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype. Cancer Res 59(15):3588–3591

    PubMed  CAS  Google Scholar 

  • Yaginuma Y, Nishiwaki K, Kitamura S, Hayashi H, Sengoku K, Ishikawa M (1997) Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors. Oncology (Basel) 54:502–507

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Jinan Science and Technology Bureau: independent innovation projects of university and institutes Stationed in jinan city(No. 201102060).

Author information

Authors and Affiliations

  1. Department of Pathology, The Second Hospital, Shandong University, 247#, BeiYuan Street, Jinan, Shandong, 250033, People’s Republic of China

    Cheng-jun Zhou

  2. Department of Osteology, The Second Hospital, Shandong University, 247#, BeiYuan Street, Jinan, Shandong, 250033, People’s Republic of China

    Peng Chen, Shao-jin Wang, Hong-bo Wang, Peng Ren, Xi-qian Wang, Wen-guang Liu, Wan-li Gu & Dong-qing Li

  3. Department of Pathology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong, 250012, People’s Republic of China

    Ting-guo Zhang

Authors
  1. Peng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shao-jin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong-bo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peng Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xi-qian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wen-guang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wan-li Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dong-qing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ting-guo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Cheng-jun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheng-jun Zhou.

Additional information

Peng Chen and Shao-jin Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, P., Wang, Sj., Wang, Hb. et al. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis. J Mol Hist 43, 63–70 (2012). https://doi.org/10.1007/s10735-011-9370-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-011-9370-2

Keywords

Search

Navigation